Foxon, Floe
Selya, Arielle
Gitchell, Joe
Shiffman, Saul
Funding for this research was provided by:
PinneyAssociates, Inc
JUUL Labs, Inc
Article History
Received: 5 January 2024
Accepted: 9 July 2024
First Online: 18 July 2024
Declarations
:
: This research uses only publicly available de-identified survey data. Under exemption four of NIH definitions, this research is therefore exempt from NIH human subjects research. All methods were performed in accordance with relevant guidelines and regulations.
: Not applicable.
: Through PinneyAssociates, FF, AS, JG, and SS provide consulting services on tobacco harm reduction on an exclusive basis to Juul Labs Inc. The preparation of the previously-published version of this manuscript was funded by JLI, who reviewed and provided comments on a draft manuscript of the previously-published version. The present, updated version did not receive any funding or review from JLI, and was self-funded by PinneyAssociates. The content and the decision to publish are the responsibility of the authors. JG and SS also own interest in a novel nicotine gum that has neither been developed nor commercialized.